Page 98 - ITPS-8-2
P. 98

INNOSC Theranostics and
            Pharmacological Sciences                                      Transformative natural product-drug combinations




            Table 2. Bioactive phytoconstituents from Calotropis procera leaf extract combined with ampicillin. Reproduced with permission
            from Gideon et al. 34
            Pk#          RT          Area%                      Compound name                    Molecular weight
            1            5.318         3.35        Cystamine                                         152.0
            3            5.528         2.46        4-amino-1-Pentanol                                103.0
            5            5.959         1.42        N-methoxy-1-ribofuranosyl-4-imidazolecarboxylic amide  155.0
            6            6.275         0.73        1,2,5-oxadiazol-3-carboxamide, 4,4’-azobis-, 2,2’-dioxide  284.0
            9            7.361         1.94        3,3-dimethyl-4-(1-aminoethyl)-Azetidin-2-one      142.0
            11           7.891         1.37        5-methyl-2-Heptanamine                            128.0
            20          12.065         1.36        dl-phenylephrine                                  167.0
            23          14.598         1.16        Cystine                                           240.0
            32          21.074         2.03        1,2,5-oxadiazol-3-carboxamide, 4,4’-azobis-, 2,2’-dioxide  284.0
            34          22.127         0.73        Metaraminol                                       167.0
            38          25.796         2.83        3-propoxyamphetamine                              193.0
            43          29.445         0.12        Hexadecanoic acid, methyl ester                   270.0
            49          30.437         2.68        1-docosene                                         308
            50          31.083         0.16        9-octadecenoic acid (Z)-, methyl ester            296.0
            52          36.087         0.78        3,7,11-trimethyl-2,6,10-dodecatrien-1-ol          222.0
            53          36.620        13.04        Oleic acid                                        264.0
            Abbreviations: Pk#: Number of peaks; RT: Retention time.

            Table 3. Fourier transform infrared spectroscopy analysis of guava extract, aspirin, and the guava‑aspirin mixture, with
            attributed functional groups. Reproduced with permission from Gideon 26

            FTIR functional   Wave number   Guava extract   Aspirin peaks (cm⁻¹)  Reacted guava   Associated phytochemicals
            group region    range (cm⁻¹)  peaks (cm⁻¹)                     peaks (cm⁻¹)
            O-H/N-H stretch  3,200 – 3,600  3,693.8; 3,280.1  3,488.8        3,235.3    Alcohols, phenols, amines, or
                                                                                        carboxylic acids
            C-H stretch     2,850 – 3,000  2,918.5; 2,851.4  2,870.1; 2,959.5; 2,698.6;   2,918.5  Alkanes
                                                          2,586.8; 2,545.8
            Clkanes stretch  2,100 – 2,260  2,109.7; 1,994.1  2,091.0        2,105.9    Alkynes or nitriles
            C=O stretch     1,630 – 1,820   1,617.7    1,804.0; 1,837.6; 1,751.8;   1,748.1, 1,677.3,   Ketones, aldehydes, esters, or
                                                          1,684.3; 1,602.8   1,602.8    carboxylic acids
            N-H bending     1,500 – 1,600     -                -               -        Primary and secondary amines
            C-H bending     1,400 – 1,500   1449.9        1483.5; 1457.4     1453.7     Aromatic compounds
            Abbreviation: FTIR: Fourier transform infrared spectroscopy.













            Figure 4. Antimicrobial susceptibility test for 31 prepared disks against Salmonella spp. Image reproduced with permission from Gideon et al. 39

            confirmed  the  formation  of  a  new  compound  with   combination of aspirin with guava extract may lead to a
            modified structural characteristics, suggesting that the   novel product with enhanced antibacterial properties. This



             Volume 8 Issue 2 (2025)                        92                               doi: 10.36922/itps.4068
   93   94   95   96   97   98   99   100   101   102   103